Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry

Autores INICO

Javier del Pino Montes

Otros Autores

N/A

Referencia

Pombo-Suarez, M., Sanchez-Piedra, C., Garcia-Magallón, B., Pérez-Gómez, A., Manrique-Arija, S., Martín-Doménech, R., Colazo, M., Campos, C., Campos, J., del Pino-Montes, J., Arteaga, M. J., Cea-Calvo, L., Díaz-González, F., & Gómez-Reino, J. J. (2021). Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry. Clinical Rheumatology, 40(10), 3979-3988. https://doi.org/10.1007/S10067-021-05742-3

Fecha publicación (año)
DOI

10.1007/S10067-021-05742-3